Conference Coverage

Adjuvant chemotherapy benefits high-risk sarcoma patients

Publish date: August 10, 2018

 

REPORTING FROM ASCO 2018

SOURCE: Pasquali S et al. ASCO 2018, Abstract 115118.

Pages

Recommended Reading

Trabectedin bests supportive care in advanced soft-tissue sarcomas
MDedge Hematology and Oncology
Low response rate with trofosfamide for advanced STS in elderly
MDedge Hematology and Oncology
Rapid drug alteration a bust in metastatic GIST
MDedge Hematology and Oncology
ENLIVEN: Pexidartinib improves symptoms, function in patients with advanced tenosynovial giant cell tumors
MDedge Hematology and Oncology
EPAZ: Pazopanib matches doxorubicin without the neutropenia in elderly patients
MDedge Hematology and Oncology
REGOBONE: Regorafenib shows efficacy in metastatic osteosarcoma
MDedge Hematology and Oncology
Metastatic soft tissue sarcomas respond to anlotinib
MDedge Hematology and Oncology
DESMOPAZ: Pazopanib slows disease progression of desmoid tumors
MDedge Hematology and Oncology